glucuronic acid has been researched along with E coli Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhshi, M; Behzadi, F; Ebrahimi, F; Gariz, DS; Nazarian, S; Zargan, J | 1 |
| Hajizadeh, A; Kordbacheh, E; Nazarian, S; Sadeghi, D | 1 |
| Ha, CS; Ramanjaneyulu, G; Rao, KC; Rao, KM; Rao, KS; Subha, MC | 1 |
| Gowda, DV; Madhunapantula, SV; Srivastava, A | 1 |
| Abdel-Mohsen, AM; Hebeish, A; Jancar, J; Montaser, AS; Ramadan, MA; Sahffie, NM; Sleem, AA | 1 |
| Jin, LJ; Li, HQ; Li, SY; Li, XY; Liu, JJ; Lu, YN; Uzonna, JE; Xu, YP; Zhen, YH | 1 |
| Gong, J; Huang, X; Wang, Q; Xue, F; Yu, H | 1 |
7 other study(ies) available for glucuronic acid and E coli Infections
| Article | Year |
|---|---|
Nano-encapsulation of chicken immunoglobulin (IgY) in sodium alginate nanoparticles: In vitro characterization.
Topics: Alginates; Animals; Antibodies, Bacterial; Antibodies, Immobilized; Chickens; Chlorocebus aethiops; Escherichia coli Infections; Escherichia coli O157; Glucuronic Acid; Hexuronic Acids; Immunoglobulins; Nanoparticles; Vero Cells | 2017 |
Entrapment of LTB protein in alginate nanoparticles protects against Enterotoxigenic Escherichia coli.
Topics: Adjuvants, Immunologic; Alginates; Animals; Antibodies, Bacterial; Enterotoxigenic Escherichia coli; Enterotoxins; Escherichia coli Infections; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mice; Mice, Inbred BALB C; Nanoparticles | 2018 |
Biodegradable sodium alginate-based semi-interpenetrating polymer network hydrogels for antibacterial application.
Topics: Alginates; Animals; Anti-Bacterial Agents; Bandages; Cell Line; Escherichia coli; Escherichia coli Infections; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Mice; Nanocomposites; Silver; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Development and Efficacy Assessment of an Enteric Coated Porous Tablet Loaded With F4 Fimbriae for Oral Vaccination of Piglets against F4+ Escherichia coli Infections.
Topics: Alginates; Animals; Antigens, Bacterial; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Glucuronic Acid; Hexuronic Acids; Immunity, Mucosal; Intestinal Mucosa; Polymethacrylic Acids; Powders; Swine; Tablets; Vaccination | 2016 |
Preparation and characterization of alginate/silver/nicotinamide nanocomposites for treating diabetic wounds.
Topics: Administration, Cutaneous; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bandages; Burns; Diabetes Mellitus, Experimental; Escherichia coli; Escherichia coli Infections; Glucuronic Acid; Hexuronic Acids; Metal Nanoparticles; Nanocomposites; Niacinamide; Particle Size; Rabbits; Rats; Silver; Skin; Staphylococcal Infections; Staphylococcus aureus; Streptozocin; Textiles | 2016 |
Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): in vivo evaluation in a pig model of enteric colibacillosis.
Topics: Alginates; Animals; Capsules; Chitosan; Delayed-Action Preparations; Diarrhea; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Female; Glucuronic Acid; Hexuronic Acids; Immunoglobulins; Immunotherapy; Male; Random Allocation; Swine; Swine Diseases | 2009 |
In vitro evaluation of the activity of microencapsulated carvacrol against Escherichia coli with K88 pili.
Topics: Administration, Oral; Alginates; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cymenes; Drug Compounding; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Glucuronic Acid; Hexuronic Acids; Intestine, Small; Monoterpenes; Oils, Volatile; Swine | 2009 |